Form 4 for INSP Inspire Medical Systems, Inc.
Accepted 2022-01-31 00:00:00 ET · period of report 2022-01-27 · accession 0001104659-22-009590 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-31 | 2022-01-27 | INSP | Herbert Timothy P. | CEO, Pres, Dir | M - OptEx | $2.07 | +38.0K | 140.9K | +37% | +$78.6K |
| D | 2022-01-31 | 2022-01-27 | INSP | Herbert Timothy P. | CEO, Pres, Dir | M - OptEx | $0.00 | -38.0K | 113.7K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-27 | M | A | 37,993 | $2.07 | 140,900 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-01-27 | M | D | 37,993 | $0.00 | 113,698 | D | $2.07 · — to 2024-03-30 | 37,993 Common Stock | (F4) The option is fully vested and exercisable. |